Less Ads, More Data, More Tools Register for FREE

EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source

Wed, 23rd Sep 2020 17:09

By Francesco Guarascio

BRUSSELS, Sept 23 (Reuters) - Brussels is close to wrapping
up preliminary talks with U.S. vaccine maker Novavax
for its potential COVID-19 shot, an EU source involved in the
negotiations said, as the bloc ramps up its push in the global
race to secure supplies.

The move is meant to expand to seven the portfolio of
vaccines the 27-country bloc, with a population of 450 million,
wants to secure. It would bring doses potentially available to
EU countries to more than 2 billion.

(Reporting by Francesco Guarascio; Editing by Josephine Mason
and Jan Harvey)

Related Shares

More News

BROKER RATINGS: Berenberg raises Rightmove to Hold from Sell

BROKER RATINGS: Berenberg raises Rightmove to Hold from Sell

3 Aug 21 09:32

IN BRIEF: GlaxoSmithKline seeks approval in US for use of Priorix

IN BRIEF: GlaxoSmithKline seeks approval in US for use of Priorix

2 Aug 21 21:22

Pressure grows to recall MPs to debate UK vaccine passports proposal

Pressure grows to recall MPs to debate UK vaccine passports proposal

2 Aug 21 13:00

AstraZeneca's Saphnelo gets FDA approval in US for systemic lupus

AstraZeneca's Saphnelo gets FDA approval in US for systemic lupus

2 Aug 21 08:37

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.